OrthoPediatrics holder sells 22,500 shares at $23

A ten-percent owner of ORTHOPEDIATRICS CORP reported selling 22,500 KIDS shares while retaining over 6.5 million shares.

Rhea-AI Filing Summary

ORTHOPEDIATRICS CORP (KIDS) had a Form 4 filed for a large shareholder, Squadron Capital LLC, reporting a sale of 22,500 shares of Common Stock on September 2, 2026, at a weighted average price of $23.35 per share, in transactions ranging from $23.01 to $23.74. After this sale, Squadron Capital LLC reports holding 6,504,133 shares, which it holds directly, while Squadron Capital Holdings LLC is described as its controlling member. No Rule 10b5-1 trading plan is reported for this transaction, and a footnote states the sale was undertaken by Squadron Capital LLC to provide additional capital for its other portfolio businesses.

Insider Trade Summary

Net Seller: 22,500 shares

Net Sell 1 txn

Insider Squadron Capital LLC, Squadron Capital Holdings LLC

Role 10% Owner | 10% Owner

Sold 22,500 shs ($525K)

Type	Security	Shares	Price	Value
Sale	Common Stock F1, F2, F3	22,500	$23.35	$525K

Holdings After Transaction: Common Stock — 6,504,133 shares (Direct)

Footnotes (3)

1. F1. This sale was undertaken by Squadron Capital LLC to provide additional capital for its other portfolio businesses.
2. F2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.01 to $23.74, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
3. F3. These securities are held directly by Squadron Capital LLC. Squadron Capital Holdings LLC is the controlling member of Squadron Capital LLC.

Key Figures

Shares sold: 22,500 shares Weighted average sale price: $23.35 per share Sale price range: $23.01–$23.74 per share +1 more

4 metrics

Shares sold 22,500 shares Non-derivative sale on September 2, 2026 by Squadron Capital LLC

Weighted average sale price $23.35 per share Common Stock sale; individual trades ranged from $23.01 to $23.74

Sale price range $23.01–$23.74 per share Price range for multiple sale transactions on September 2, 2026

Shares held after transaction 6,504,133 shares Common Stock directly held by Squadron Capital LLC following the sale

Key Terms

weighted average price, ten percent owner, controlling member

3 terms

weighted average price financial

"The price reported in Column 4 is a weighted average price."

Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.

ten percent owner regulatory

"each reporting person is identified as a ten percent owner."

controlling member financial

"Squadron Capital Holdings LLC is the controlling member of Squadron Capital LLC."

FAQ

What insider transaction in KIDS did Squadron Capital LLC report?

The filing reports that Squadron Capital LLC sold 22,500 shares of ORTHOPEDIATRICS CORP Common Stock on September 2, 2026, in a sale classified as a non-derivative transaction.

At what price were the KIDS shares sold in this Form 4?

The sale was reported at a weighted average price of $23.35 per share. A footnote explains the shares were sold in multiple transactions at prices ranging from $23.01 to $23.74, and detailed breakdowns are available upon request.

How many KIDS shares does Squadron Capital LLC hold after this sale?

After the reported sale, Squadron Capital LLC holds 6,504,133 shares of ORTHOPEDIATRICS CORP Common Stock, according to the Form 4’s post-transaction holdings figure.

Was the KIDS insider sale made under a Rule 10b5-1 trading plan?

No. The Form 4 indicates that no Rule 10b5-1 trading plan applies to this transaction, and no footnote states that the sale was made pursuant to such a plan.

Who are the reporting persons in this KIDS Form 4 filing?

The reporting persons are Squadron Capital LLC and Squadron Capital Holdings LLC, each identified as a ten percent owner. A footnote states the securities are held directly by Squadron Capital LLC and that Squadron Capital Holdings LLC is its controlling member.

Why did Squadron Capital LLC sell KIDS shares according to the filing?

A footnote states the sale was undertaken by Squadron Capital LLC to provide additional capital for its other portfolio businesses. No further details on those businesses or amounts are provided in the Form 4.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/04/2026 - 04:42 PM Accepted by SEC EDGAR 09/04/2026 - 04:42 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Squadron Capital LLC

(Last) (First) (Middle)

18 HARTFORD AVE., PO BOX 223

(Street)

GRANBY CONNECTICUT 06035

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
ORTHOPEDIATRICS CORP [ KIDS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	X	10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
09/02/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

	Form filed by One Reporting Person
X	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/02/2026		S(1)		22,500	D	$23.35(2)	6,504,133	D(3)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

1. Name and Address of Reporting Person^*

Squadron Capital LLC

(Last) (First) (Middle)

18 HARTFORD AVE., PO BOX 223

(Street)

GRANBY CONNECTICUT 06035

(City) (State) (Zip)

UNITED STATES

(Country)

Relationship of Reporting Person(s) to Issuer

	Director	X	10% Owner
	Officer (give title below)		Other (specify below)

1. Name and Address of Reporting Person^*

Squadron Capital Holdings LLC

(Last) (First) (Middle)

104 S. MICHIGAN AVE.

(Street)

CHICAGO ILLINOIS 60603

(City) (State) (Zip)

UNITED STATES

(Country)

Relationship of Reporting Person(s) to Issuer

	Director	X	10% Owner
	Officer (give title below)		Other (specify below)

Explanation of Responses:

1. This sale was undertaken by Squadron Capital LLC to provide additional capital for its other portfolio businesses.

2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.01 to $23.74, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

3. These securities are held directly by Squadron Capital LLC. Squadron Capital Holdings LLC is the controlling member of Squadron Capital LLC.

	/s/ David R. Pelizzon, President of Squadron Capital LLC	09/04/2026
	/s/ Mary Falcon, Manager of Squadron Capital Holdings LLC	09/04/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)